IMGN logo

ImmunoGen (IMGN) Cash From Operations

Annual CFO

-$229.80 M
-$60.39 M-35.64%

December 31, 2022

Summary

Performance

1-Year Change

-35.64%

3-Year Change

-160.05%

5-Year Change

-3105.91%

15-Year Change

-3105.91%

IMGN Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$7.64 M
IMGN annual cash flow from operations is currently -3105.91% below its historical high of $7.64 million

3-Year Low

-$229.80 M
IMGN annual cash flow from operations is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
IMGN previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
IMGN next annual earnings announcement has not yet been scheduled

OtherIMGNcash flowmetrics:

Annual CFI

-$1.36 M
IMGN annual cash flow from investing activities is -$1.36 million

Annual CFF

$27.55 M
IMGN annual cash flow from financing activities is $27.55 million

Annual FCF

-$231.17 M
IMGN annual free cash flow is -$231.17 million

Annual CAPEX

$1.36 M
IMGN annual capital expenditures is $1.36 million

Quarterly CFO

$2.77 M
+$69.51 M+104.15%

September 30, 2023

Summary

Performance

3-Month Change

+104.15%

1-Year Change

+104.31%

3-Year Change

+109.04%

5-Year Change

+106.95%

IMGN Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$45.93 M
IMGN quarterly cash flow from operations is currently -93.97% below its historical high of $45.93 million

3-Year Low

-$73.72 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
IMGN previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
IMGN next earnings announcement has not yet been scheduled

OtherIMGNcash flowmetrics:

Quarterly CFI

-$1.35 M
IMGN quarterly cash flow from investing activities is -$1.35 million

Quarterly CFF

$32.13 M
IMGN quarterly cash flow from financing activities is $32.13 million

Quarterly FCF

$1.42 M
IMGN quarterly free cash flow is $1.42 million

Quarterly CAPEX

$1.35 M
IMGN quarterly capital expenditures is $1.35 million

TTM CFO

-$197.89 M
+$66.98 M+25.29%

September 30, 2023

Summary

Performance

3-Month Change

+25.29%

1-Year Change

+8.16%

3-Year Change

-65.3%

5-Year Change

-123.94%

IMGN TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$37.05 M
IMGN TTM cash flow from operations is currently -634.06% below its historical high of $37.05 million

3-Year Low

-$264.87 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
IMGN previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
IMGN next earnings announcement has not yet been scheduled

OtherIMGNcash flowmetrics:

TTM CFI

-$1.89 M
IMGN TTM cash flow from investing activities is -$1.89 million

TTM CFF

$495.80 M
IMGN TTM cash flow from financing activities is $495.80 million

TTM FCF

-$199.78 M
IMGN TTM free cash flow is -$199.78 million

TTM CAPEX

$1.89 M
IMGN TTM capital expenditures is $1.89 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

IMGN Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-35.6%+104.3%+8.2%
3 y3 years-160.1%+109.0%-65.3%
5 y5 years-3105.9%+107.0%-123.9%

IMGN Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+35.6%at lowat high-2761.3%+19.1%+33.8%
5 y5-year+192.3%at low-67.5%-2761.3%+151.7%+33.8%
alltimeall time-3105.9%at low-94.0%-2761.3%-634.1%+33.8%

ImmunoGen Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2023
-
$2.77 M(-104.2%)
-$197.89 M(-25.3%)
Jun 2023
-
-$66.74 M(-9.5%)
-$264.87 M(+1.0%)
Mar 2023
-
-$73.72 M(+22.5%)
-$262.12 M(+14.1%)
Dec 2022
-$229.80 M(+35.6%)
-$60.20 M(-6.2%)
-$229.80 M(+6.6%)
Sep 2022
-
-$64.21 M(+0.3%)
-$215.48 M(+15.7%)
Jun 2022
-
-$63.99 M(+54.6%)
-$186.31 M(+12.1%)
Mar 2022
-
-$41.40 M(-9.7%)
-$166.20 M(-1.9%)
Dec 2021
-$169.42 M(+115.5%)
-$45.87 M(+30.9%)
-$169.42 M(+47.3%)
Sep 2021
-
-$35.04 M(-20.1%)
-$115.01 M(+4.0%)
Jun 2021
-
-$43.88 M(-1.7%)
-$110.61 M(+16.5%)
Mar 2021
-
-$44.62 M(-622.8%)
-$94.93 M(+20.7%)
Dec 2020
-$78.62 M(-11.0%)
$8.54 M(-127.8%)
-$78.62 M(-34.3%)
Sep 2020
-
-$30.65 M(+8.7%)
-$119.71 M(-3.5%)
Jun 2020
-
-$28.19 M(-0.4%)
-$124.06 M(-2.2%)
Mar 2020
-
-$28.32 M(-13.0%)
-$126.89 M(+43.6%)
Dec 2019
-$88.37 M(-46.9%)
-$32.56 M(-7.0%)
-$88.37 M(-9.0%)
Sep 2019
-
-$35.00 M(+12.9%)
-$97.09 M(-4.8%)
Jun 2019
-
-$31.01 M(-404.0%)
-$101.95 M(-4.1%)
Mar 2019
-
$10.20 M(-124.7%)
-$106.26 M(-36.1%)
Dec 2018
-$166.42 M(-2276.9%)
-$41.28 M(+3.6%)
-$166.42 M(+7.7%)
Sep 2018
-
-$39.86 M(+12.8%)
-$154.55 M(+124.8%)
Jun 2018
-
-$35.33 M(-29.3%)
-$68.76 M(+635.3%)
Mar 2018
-
-$49.95 M(+69.9%)
-$9.35 M(-222.3%)
Dec 2017
$7.64 M(-109.1%)
-$29.41 M(-164.0%)
$7.64 M(-79.4%)
Sep 2017
-
$45.93 M(+90.8%)
$37.05 M(-165.3%)
Jun 2017
-
$24.08 M(-173.1%)
-$56.72 M(-50.1%)
Mar 2017
-
-$32.96 M(-31.1%)
-$113.71 M(-19.3%)
Dec 2016
-$83.66 M(-32.8%)
-
-
Sep 2016
-
-$47.84 M(+45.4%)
-$140.97 M(+13.2%)
Jun 2016
-$124.48 M(+125.1%)
-$32.91 M(+26.2%)
-$124.48 M(+3.7%)
Mar 2016
-
-$26.08 M(-23.6%)
-$120.02 M(+38.9%)
Dec 2015
-
-$34.14 M(+8.9%)
-$86.40 M(+27.5%)
Sep 2015
-
-$31.35 M(+10.2%)
-$67.74 M(+22.5%)
Jun 2015
-$55.29 M(+3.1%)
-$28.45 M(-477.1%)
-$55.29 M(+20.8%)
Mar 2015
-
$7.54 M(-148.7%)
-$45.76 M(-31.1%)
Dec 2014
-
-$15.48 M(-18.1%)
-$66.40 M(+35.6%)
Sep 2014
-
-$18.90 M(-0.1%)
-$48.97 M(-8.7%)
Jun 2014
-$53.65 M(-11.0%)
-$18.92 M(+44.4%)
-$53.65 M(+15.8%)
Mar 2014
-
-$13.10 M(-773.2%)
-$46.34 M(+18.2%)
Dec 2013
-
$1.95 M(-108.3%)
-$39.22 M(-37.6%)
Sep 2013
-
-$23.57 M(+103.0%)
-$62.87 M(+4.3%)
Jun 2013
-$60.30 M(+75.9%)
-$11.61 M(+94.2%)
-$60.30 M(-7.0%)
Mar 2013
-
-$5.98 M(-72.5%)
-$64.86 M(+22.5%)
Dec 2012
-
-$21.70 M(+3.3%)
-$52.96 M(+21.1%)
Sep 2012
-
-$21.01 M(+29.9%)
-$43.73 M(+27.5%)
Jun 2012
-$34.29 M(+329.2%)
-$16.17 M(-373.2%)
-$34.29 M(+7.0%)
Mar 2012
-
$5.92 M(-147.5%)
-$32.05 M(-36.4%)
Dec 2011
-
-$12.47 M(+7.8%)
-$50.42 M(+1080.5%)
Sep 2011
-
-$11.56 M(-17.0%)
-$4.27 M(-46.5%)
Jun 2011
-$7.99 M(-80.3%)
-$13.93 M(+11.9%)
-$7.99 M(+111.7%)
Mar 2011
-
-$12.45 M(-137.0%)
-$3.77 M(+96.3%)
Dec 2010
-
$33.68 M(-320.4%)
-$1.92 M(-95.7%)
Sep 2010
-
-$15.28 M(+57.3%)
-$44.46 M(+9.5%)
Jun 2010
-$40.58 M(+204.4%)
-$9.72 M(-8.3%)
-$40.58 M(-1.6%)
Mar 2010
-
-$10.60 M(+19.7%)
-$41.25 M(+24.2%)
Dec 2009
-
-$8.86 M(-22.4%)
-$33.22 M(+49.8%)
Sep 2009
-
-$11.41 M(+9.9%)
-$22.17 M(+66.3%)
Jun 2009
-$13.33 M(-33.8%)
-$10.38 M(+303.6%)
-$13.33 M(-35.1%)
Mar 2009
-
-$2.57 M(-217.3%)
-$20.55 M(+50.7%)
Dec 2008
-
$2.19 M(-185.3%)
-$13.64 M(-19.2%)
Sep 2008
-
-$2.57 M(-85.4%)
-$16.88 M(-16.2%)
Jun 2008
-$20.15 M(+27.7%)
-$17.60 M(-505.7%)
-$20.15 M(+195.8%)
Mar 2008
-
$4.34 M(-516.8%)
-$6.81 M(-53.8%)
Dec 2007
-
-$1.04 M(-82.2%)
-$14.74 M(-13.7%)
Sep 2007
-
-$5.84 M(+37.0%)
-$17.07 M(+8.1%)
Jun 2007
-$15.78 M
-$4.27 M(+19.0%)
-$15.78 M(-15.7%)
DateAnnualQuarterlyTTM
Mar 2007
-
-$3.58 M(+6.3%)
-$18.72 M(+6.6%)
Dec 2006
-
-$3.37 M(-26.0%)
-$17.57 M(+14.3%)
Sep 2006
-
-$4.56 M(-36.8%)
-$15.38 M(+7.7%)
Jun 2006
-$14.28 M(+591.6%)
-$7.21 M(+196.5%)
-$14.28 M(+87.4%)
Mar 2006
-
-$2.43 M(+106.0%)
-$7.62 M(+14.4%)
Dec 2005
-
-$1.18 M(-65.9%)
-$6.67 M(+4.1%)
Sep 2005
-
-$3.46 M(+531.9%)
-$6.40 M(+210.1%)
Jun 2005
-$2.06 M(-58.8%)
-$548.00 K(-62.8%)
-$2.06 M(-75.7%)
Mar 2005
-
-$1.47 M(+60.4%)
-$8.51 M(+49.3%)
Dec 2004
-
-$919.00 K(-204.9%)
-$5.70 M(-46.4%)
Sep 2004
-
$876.00 K(-112.5%)
-$10.63 M(+111.8%)
Jun 2004
-$5.02 M(-77.1%)
-$6.99 M(-623.4%)
-$5.02 M(-13.9%)
Mar 2004
-
$1.34 M(-122.8%)
-$5.83 M(-56.0%)
Dec 2003
-
-$5.85 M(-190.1%)
-$13.24 M(+38.2%)
Sep 2003
-
$6.49 M(-183.1%)
-$9.59 M(-56.2%)
Jun 2003
-$21.88 M(+36.7%)
-$7.80 M(+28.3%)
-$21.88 M(+10.7%)
Mar 2003
-
-$6.08 M(+177.9%)
-$19.78 M(+5.3%)
Dec 2002
-
-$2.19 M(-62.4%)
-$18.79 M(+5.4%)
Sep 2002
-
-$5.81 M(+2.1%)
-$17.83 M(+11.4%)
Jun 2002
-$16.00 M(+144.4%)
-$5.69 M(+11.8%)
-$16.00 M(+5.5%)
Mar 2002
-
-$5.09 M(+314.7%)
-$15.17 M(+28.7%)
Dec 2001
-
-$1.23 M(-69.2%)
-$11.79 M(+53.4%)
Sep 2001
-
-$3.99 M(-18.0%)
-$7.69 M(+17.4%)
Jun 2001
-$6.55 M(-376.3%)
-$4.86 M(+184.5%)
-$6.55 M(-523.1%)
Mar 2001
-
-$1.71 M(-159.5%)
$1.55 M(-49.6%)
Dec 2000
-
$2.88 M(-200.9%)
$3.07 M(+78.4%)
Sep 2000
-
-$2.85 M(-188.2%)
$1.72 M(-27.4%)
Jun 2000
$2.37 M(-167.7%)
$3.23 M(-1813.3%)
$2.37 M(-410.9%)
Mar 2000
-
-$188.60 K(-112.4%)
-$762.00 K(-29.0%)
Dec 1999
-
$1.53 M(-169.4%)
-$1.07 M(-73.2%)
Sep 1999
-
-$2.20 M(-2300.0%)
-$4.00 M(+14.3%)
Jun 1999
-$3.50 M(-41.7%)
$100.00 K(-120.0%)
-$3.50 M(-30.0%)
Mar 1999
-
-$500.00 K(-64.3%)
-$5.00 M(-23.1%)
Dec 1998
-
-$1.40 M(-17.6%)
-$6.50 M(+4.8%)
Sep 1998
-
-$1.70 M(+21.4%)
-$6.20 M(+3.3%)
Jun 1998
-$6.00 M(-25.0%)
-$1.40 M(-30.0%)
-$6.00 M(-4.8%)
Mar 1998
-
-$2.00 M(+81.8%)
-$6.30 M(-6.0%)
Dec 1997
-
-$1.10 M(-26.7%)
-$6.70 M(-13.0%)
Sep 1997
-
-$1.50 M(-11.8%)
-$7.70 M(-3.8%)
Jun 1997
-$8.00 M(-7.0%)
-$1.70 M(-29.2%)
-$8.00 M(+2.6%)
Mar 1997
-
-$2.40 M(+14.3%)
-$7.80 M(+9.9%)
Dec 1996
-
-$2.10 M(+16.7%)
-$7.10 M(+2.9%)
Sep 1996
-
-$1.80 M(+20.0%)
-$6.90 M(-19.8%)
Jun 1996
-$8.60 M(-48.5%)
-$1.50 M(-11.8%)
-$8.60 M(+21.1%)
Mar 1996
-
-$1.70 M(-10.5%)
-$7.10 M(+31.5%)
Dec 1995
-
-$1.90 M(-45.7%)
-$5.40 M(+54.3%)
Sep 1995
-
-$3.50 M(-37.5%)
-$3.50 M(-83.3%)
Jun 1995
-$16.70 M(-22.3%)
-
-
Sep 1994
-
-$5.60 M(-11.1%)
-$21.00 M(-2.3%)
Jun 1994
-$21.50 M(+39.6%)
-$6.30 M(+80.0%)
-$21.50 M(+13.8%)
Mar 1994
-
-$3.50 M(-37.5%)
-$18.90 M(+0.5%)
Dec 1993
-
-$5.60 M(-8.2%)
-$18.80 M(+8.0%)
Sep 1993
-
-$6.10 M(+64.9%)
-$17.40 M(+13.0%)
Jun 1993
-$15.40 M(+13.2%)
-$3.70 M(+8.8%)
-$15.40 M(+31.6%)
Mar 1993
-
-$3.40 M(-19.0%)
-$11.70 M(+41.0%)
Dec 1992
-
-$4.20 M(+2.4%)
-$8.30 M(+102.4%)
Sep 1992
-
-$4.10 M(+17.1%)
-$4.10 M(-65.0%)
Jun 1992
-$13.60 M(+63.9%)
-
-
Sep 1991
-
-$3.50 M(+20.7%)
-$11.70 M(+41.0%)
Jun 1991
-$8.30 M(+22.1%)
-$2.90 M(+16.0%)
-$8.30 M(+53.7%)
Mar 1991
-
-$2.50 M(-10.7%)
-$5.40 M(+86.2%)
Dec 1990
-
-$2.80 M(+2700.0%)
-$2.90 M(+2800.0%)
Sep 1990
-
-$100.00 K(-92.9%)
-$100.00 K(-92.9%)
Jun 1990
-$6.80 M(+44.7%)
-
-
Sep 1989
-
-$1.40 M
-$1.40 M
Jun 1989
-$4.70 M
-
-

FAQ

  • What is ImmunoGen annual cash flow from operations?
  • What is the all time high annual CFO for ImmunoGen?
  • What is ImmunoGen annual CFO year-on-year change?
  • What is ImmunoGen quarterly cash flow from operations?
  • What is the all time high quarterly CFO for ImmunoGen?
  • What is ImmunoGen quarterly CFO year-on-year change?
  • What is ImmunoGen TTM cash flow from operations?
  • What is the all time high TTM CFO for ImmunoGen?
  • What is ImmunoGen TTM CFO year-on-year change?

What is ImmunoGen annual cash flow from operations?

The current annual CFO of IMGN is -$229.80 M

What is the all time high annual CFO for ImmunoGen?

ImmunoGen all-time high annual cash flow from operations is $7.64 M

What is ImmunoGen annual CFO year-on-year change?

Over the past year, IMGN annual cash flow from operations has changed by -$60.39 M (-35.64%)

What is ImmunoGen quarterly cash flow from operations?

The current quarterly CFO of IMGN is $2.77 M

What is the all time high quarterly CFO for ImmunoGen?

ImmunoGen all-time high quarterly cash flow from operations is $45.93 M

What is ImmunoGen quarterly CFO year-on-year change?

Over the past year, IMGN quarterly cash flow from operations has changed by +$66.98 M (+104.31%)

What is ImmunoGen TTM cash flow from operations?

The current TTM CFO of IMGN is -$197.89 M

What is the all time high TTM CFO for ImmunoGen?

ImmunoGen all-time high TTM cash flow from operations is $37.05 M

What is ImmunoGen TTM CFO year-on-year change?

Over the past year, IMGN TTM cash flow from operations has changed by +$17.59 M (+8.16%)